Female Health Market - Global Outlook and Forecast 2021-2027

March 2021 | 92 pages | ID: F5BA0BDBE6D5EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Female Health in Global, including the following market information:

Global Female Health Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Female Health market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Female Health companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Female Health Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Female Health Market Segment Percentages, By Type, 2020 (%)

• Medicines
• Treatment
• Other

China Female Health Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Female Health Market Segment Percentages, By Application, 2020 (%)

• Postmenopausal Osteoporosis
• Infertility
• Endometriosis
• PCOS
• Other

Global Female Health Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Female Health Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Female Health Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Female Health Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Veru Inc.
• Allergan
• Bayer AG
• Merck
• Pfizer
• Teva Pharmaceuticals
• Agile Therapeutics
• Amgen, Inc.
• AstraZeneca
• Bristol-Myers Squibb

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Female Health Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Female Health Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL FEMALE HEALTH OVERALL MARKET SIZE

2.1 Global Female Health Market Size: 2021 VS 2027
2.2 Global Female Health Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Female Health Players in Global Market
3.2 Top Global Female Health Companies Ranked by Revenue
3.3 Global Female Health Revenue by Companies
3.4 Top 3 and Top 5 Female Health Companies in Global Market, by Revenue in 2020
3.5 Global Companies Female Health Product Type
3.6 Tier 1, Tier 2 and Tier 3 Female Health Players in Global Market
  3.6.1 List of Global Tier 1 Female Health Companies
  3.6.2 List of Global Tier 2 and Tier 3 Female Health Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Female Health Market Size Markets, 2021 & 2027
  4.1.2 Medicines
  4.1.3 Treatment
  4.1.4 Other
4.2 By Type - Global Female Health Revenue & Forecasts
  4.2.1 By Type - Global Female Health Revenue, 2016-2021
  4.2.2 By Type - Global Female Health Revenue, 2022-2027
  4.2.3 By Type - Global Female Health Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Female Health Market Size, 2021 & 2027
  5.1.2 Postmenopausal Osteoporosis
  5.1.3 Infertility
  5.1.4 Endometriosis
  5.1.5 PCOS
  5.1.6 Other
5.2 By Application - Global Female Health Revenue & Forecasts
  5.2.1 By Application - Global Female Health Revenue, 2016-2021
  5.2.2 By Application - Global Female Health Revenue, 2022-2027
  5.2.3 By Application - Global Female Health Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Female Health Market Size, 2021 & 2027
6.2 By Region - Global Female Health Revenue & Forecasts
  6.2.1 By Region - Global Female Health Revenue, 2016-2021
  6.2.2 By Region - Global Female Health Revenue, 2022-2027
  6.2.3 By Region - Global Female Health Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Female Health Revenue, 2016-2027
  6.3.2 US Female Health Market Size, 2016-2027
  6.3.3 Canada Female Health Market Size, 2016-2027
  6.3.4 Mexico Female Health Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Female Health Revenue, 2016-2027
  6.4.2 Germany Female Health Market Size, 2016-2027
  6.4.3 France Female Health Market Size, 2016-2027
  6.4.4 U.K. Female Health Market Size, 2016-2027
  6.4.5 Italy Female Health Market Size, 2016-2027
  6.4.6 Russia Female Health Market Size, 2016-2027
  6.4.7 Nordic Countries Female Health Market Size, 2016-2027
  6.4.8 Benelux Female Health Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Female Health Revenue, 2016-2027
  6.5.2 China Female Health Market Size, 2016-2027
  6.5.3 Japan Female Health Market Size, 2016-2027
  6.5.4 South Korea Female Health Market Size, 2016-2027
  6.5.5 Southeast Asia Female Health Market Size, 2016-2027
  6.5.6 India Female Health Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Female Health Revenue, 2016-2027
  6.6.2 Brazil Female Health Market Size, 2016-2027
  6.6.3 Argentina Female Health Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Female Health Revenue, 2016-2027
  6.7.2 Turkey Female Health Market Size, 2016-2027
  6.7.3 Israel Female Health Market Size, 2016-2027
  6.7.4 Saudi Arabia Female Health Market Size, 2016-2027
  6.7.5 UAE Female Health Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Veru Inc.
  7.1.1 Veru Inc. Corporate Summary
  7.1.2 Veru Inc. Business Overview
  7.1.3 Veru Inc. Female Health Major Product Offerings
  7.1.4 Veru Inc. Female Health Revenue in Global (2016-2021)
  7.1.5 Veru Inc. Key News
7.2 Allergan
  7.2.1 Allergan Corporate Summary
  7.2.2 Allergan Business Overview
  7.2.3 Allergan Female Health Major Product Offerings
  7.2.4 Allergan Female Health Revenue in Global (2016-2021)
  7.2.5 Allergan Key News
7.3 Bayer AG
  7.3.1 Bayer AG Corporate Summary
  7.3.2 Bayer AG Business Overview
  7.3.3 Bayer AG Female Health Major Product Offerings
  7.3.4 Bayer AG Female Health Revenue in Global (2016-2021)
  7.3.5 Bayer AG Key News
7.4 Merck
  7.4.1 Merck Corporate Summary
  7.4.2 Merck Business Overview
  7.4.3 Merck Female Health Major Product Offerings
  7.4.4 Merck Female Health Revenue in Global (2016-2021)
  7.4.5 Merck Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Female Health Major Product Offerings
  7.5.4 Pfizer Female Health Revenue in Global (2016-2021)
  7.5.5 Pfizer Key News
7.6 Teva Pharmaceuticals
  7.6.1 Teva Pharmaceuticals Corporate Summary
  7.6.2 Teva Pharmaceuticals Business Overview
  7.6.3 Teva Pharmaceuticals Female Health Major Product Offerings
  7.6.4 Teva Pharmaceuticals Female Health Revenue in Global (2016-2021)
  7.6.5 Teva Pharmaceuticals Key News
7.7 Agile Therapeutics
  7.7.1 Agile Therapeutics Corporate Summary
  7.7.2 Agile Therapeutics Business Overview
  7.7.3 Agile Therapeutics Female Health Major Product Offerings
  7.4.4 Agile Therapeutics Female Health Revenue in Global (2016-2021)
  7.7.5 Agile Therapeutics Key News
7.8 Amgen, Inc.
  7.8.1 Amgen, Inc. Corporate Summary
  7.8.2 Amgen, Inc. Business Overview
  7.8.3 Amgen, Inc. Female Health Major Product Offerings
  7.8.4 Amgen, Inc. Female Health Revenue in Global (2016-2021)
  7.8.5 Amgen, Inc. Key News
7.9 AstraZeneca
  7.9.1 AstraZeneca Corporate Summary
  7.9.2 AstraZeneca Business Overview
  7.9.3 AstraZeneca Female Health Major Product Offerings
  7.9.4 AstraZeneca Female Health Revenue in Global (2016-2021)
  7.9.5 AstraZeneca Key News
7.10 Bristol-Myers Squibb
  7.10.1 Bristol-Myers Squibb Corporate Summary
  7.10.2 Bristol-Myers Squibb Business Overview
  7.10.3 Bristol-Myers Squibb Female Health Major Product Offerings
  7.10.4 Bristol-Myers Squibb Female Health Revenue in Global (2016-2021)
  7.10.5 Bristol-Myers Squibb Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Female Health Market Opportunities & Trends in Global Market
Table 2. Female Health Market Drivers in Global Market
Table 3. Female Health Market Restraints in Global Market
Table 4. Key Players of Female Health in Global Market
Table 5. Top Female Health Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Female Health Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Female Health Revenue Share by Companies, 2016-2021
Table 8. Global Companies Female Health Product Type
Table 9. List of Global Tier 1 Female Health Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Female Health Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Female Health Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Female Health Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Female Health Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Female Health Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Female Health Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Female Health Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Female Health Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Female Health Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Female Health Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Female Health Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Female Health Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Female Health Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Female Health Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Female Health Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Female Health Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Female Health Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Female Health Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Female Health Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Female Health Revenue, (US$, Mn), 2022-2027
Table 30. Veru Inc. Corporate Summary
Table 31. Veru Inc. Female Health Product Offerings
Table 32. Veru Inc. Female Health Revenue (US$, Mn), (2016-2021)
Table 33. Allergan Corporate Summary
Table 34. Allergan Female Health Product Offerings
Table 35. Allergan Female Health Revenue (US$, Mn), (2016-2021)
Table 36. Bayer AG Corporate Summary
Table 37. Bayer AG Female Health Product Offerings
Table 38. Bayer AG Female Health Revenue (US$, Mn), (2016-2021)
Table 39. Merck Corporate Summary
Table 40. Merck Female Health Product Offerings
Table 41. Merck Female Health Revenue (US$, Mn), (2016-2021)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Female Health Product Offerings
Table 44. Pfizer Female Health Revenue (US$, Mn), (2016-2021)
Table 45. Teva Pharmaceuticals Corporate Summary
Table 46. Teva Pharmaceuticals Female Health Product Offerings
Table 47. Teva Pharmaceuticals Female Health Revenue (US$, Mn), (2016-2021)
Table 48. Agile Therapeutics Corporate Summary
Table 49. Agile Therapeutics Female Health Product Offerings
Table 50. Agile Therapeutics Female Health Revenue (US$, Mn), (2016-2021)
Table 51. Amgen, Inc. Corporate Summary
Table 52. Amgen, Inc. Female Health Product Offerings
Table 53. Amgen, Inc. Female Health Revenue (US$, Mn), (2016-2021)
Table 54. AstraZeneca Corporate Summary
Table 55. AstraZeneca Female Health Product Offerings
Table 56. AstraZeneca Female Health Revenue (US$, Mn), (2016-2021)
Table 57. Bristol-Myers Squibb Corporate Summary
Table 58. Bristol-Myers Squibb Female Health Product Offerings
Table 59. Bristol-Myers Squibb Female Health Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Female Health Segment by Type
Figure 2. Female Health Segment by Application
Figure 3. Global Female Health Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Female Health Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Female Health Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Female Health Revenue in 2020
Figure 8. By Type - Global Female Health Revenue Market Share, 2016-2027
Figure 9. By Application - Global Female Health Revenue Market Share, 2016-2027
Figure 10. By Region - Global Female Health Revenue Market Share, 2016-2027
Figure 11. By Country - North America Female Health Revenue Market Share, 2016-2027
Figure 12. US Female Health Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Female Health Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Female Health Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Female Health Revenue Market Share, 2016-2027
Figure 16. Germany Female Health Revenue, (US$, Mn), 2016-2027
Figure 17. France Female Health Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Female Health Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Female Health Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Female Health Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Female Health Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Female Health Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Female Health Revenue Market Share, 2016-2027
Figure 24. China Female Health Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Female Health Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Female Health Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Female Health Revenue, (US$, Mn), 2016-2027
Figure 28. India Female Health Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Female Health Revenue Market Share, 2016-2027
Figure 30. Brazil Female Health Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Female Health Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Female Health Revenue Market Share, 2016-2027
Figure 33. Turkey Female Health Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Female Health Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Female Health Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Female Health Revenue, (US$, Mn), 2016-2027
Figure 37. Veru Inc. Female Health Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Allergan Female Health Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Bayer AG Female Health Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Merck Female Health Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Pfizer Female Health Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Teva Pharmaceuticals Female Health Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Agile Therapeutics Female Health Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Amgen, Inc. Female Health Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. AstraZeneca Female Health Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Bristol-Myers Squibb Female Health Revenue Year Over Year Growth (US$, Mn) & (2016-2021)